Structural imaging provides a means to visualize change in anatomy associated with cognitive decline (e.g., Project 3 """"""""Attention Profiles in Healthy Aging and Early Stage DAT"""""""") and also candidate surrogate markers for detection of early-stage DAT in combination with other biomarkers (e.g., Project 2 """"""""Antecedent biomarkers of AD in CSF""""""""). The goal of the Core E: Imaging is to collect, store, and disseminate imaging data for the use of the present program project investigations and also to facilitate the development of infrastructure to support future imaging projects. The following Specific Aims will be pursued: 1. Structural imaging data on demented and nondemented participants will be collected, in close coordination with Core B: Clinical, at two-year longitudinal intervals. The structural imaging battery will include (i) multiple acquisitions of high contrast MP-RAGE images, (ii)3D T2 images for assessment of white matter. These images will be used for measurement of cortical and subcortical atrophy and assessment of white matter integrity, (iii)diffusion tensor imaging to assess white matter microstructural integrity, and (iv)T2-SWI images. In addition, functional imaging data on demented and nondemented participants will be collected. The functional imaging data will be BOLD images during rest to assess functional connectivity. 2. Research neuroradiological assessment will be made by board-certified neuroradiologists on all structural image data sets. 3. Structural data sets will be archived in conjunction with Core C: Biostatistics and made available via a web-based interface to investigators to pursue research projects. 4. Quantitative structural assessment will be provided for correlating imaging data with project-specific data including (i) automated estimates of whole- brain atrophy, (ii) manual estimates of hippocampal, entorhinal, frontal, and other cortical volumes, (iii) automated estimates of cortical and subcortical volumes derived from Freesurfer software (Fischl et al., 2002;Fischl et al., 2004;Desikan et al., 2006), and (iv) automated assessment of white matter hyperintensities. Quantitative functional assessment will also be provided for correlating imaging data with project-specific data and will include estimates of the functional connectivity between seed regions such as the hippocampus and the precuneus. 5. Working closely with Core C: Biostatistics and Core A: Administration, data will be managed to integrate the Core's function with the scientific goals of the program project.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-28
Application #
8215303
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
28
Fiscal Year
2011
Total Cost
$144,048
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Rao, Shuquan; Ghani, Mahdi; Guo, Zhiyun et al. (2018) An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk. Neurobiol Aging 66:178.e1-178.e8
Roe, Catherine M; Babulal, Ganesh M; Mishra, Shruti et al. (2018) Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. J Alzheimers Dis 61:509-513
Peloso, Gina M; van der Lee, Sven J; International Genomics of Alzheimer's Project (IGAP) et al. (2018) Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst) 10:595-598
Laurido-Soto, Osvaldo; Brier, Matthew R; Simon, Laura E et al. (2018) Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol :
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 98:861-864
Armstrong, Richard A; McKee, Ann C; Stein, Thor D et al. (2018) Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change. Neurol Sci :
Millar, Peter R; Balota, David A; Bishara, Anthony J et al. (2018) Multinomial models reveal deficits of two distinct controlled retrieval processes in aging and very mild Alzheimer disease. Mem Cognit 46:1058-1075
Deming, Yuetiva; Li, Zeran; Benitez, Bruno A et al. (2018) Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opin Ther Targets 22:587-598
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Musiek, Erik S; Bhimasani, Meghana; Zangrilli, Margaret A et al. (2018) Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. JAMA Neurol 75:582-590

Showing the most recent 10 out of 911 publications